Healthcare - Biotechnology - NASDAQ - FR
$ 1.44
-11.7 %
$ 117 M
Market Cap
-3.27
P/E
INCOME STATEMENT
51.9 M
REVENUE
-12.7 M
OPERATING INCOME
-7.57 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Innate Pharma S.A.
| Revenue | 51.9 M |
| Cost Of Revenue | 56 M |
| Gross Profit | -4.12 M |
| Operating Expenses | 64.6 M |
| Operating Income | -12.7 M |
| Other Expenses | -5.1 M |
| Net Income | -7.57 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||
| Revenue | 51.9 | 49.6 | 12.1 | 56.8 | 69.0 | 79.9 | 32.6 | 56.2 | 17.9 | 0.9 | 12.5 | 10.4 | 11.7 | 4.3 | 7.7 | 12.9 | 14.3 | 6.2 | 1.3 |
| GROSS PROFIT | |||||||||||||||||||
| Cost Of Revenue | 56.0 | 51.7 | 47.0 | 3.0 | 45.2 | 69.6 | 67.0 | 48.6 | 29.9 | 12.1 | 7.6 | 6.9 | 1.6 | 3.4 | 3.3 | 2.6 | 2.8 | 2.2 | 0.9 |
| Gross Profit | (4.1) | (2.0) | (34.9) | 53.8 | 23.8 | 10.3 | (34.4) | 7.5 | (12.0) | (11.2) | 4.9 | 3.5 | 10.1 | 0.9 | 4.4 | 10.4 | 11.5 | 4.0 | 0.4 |
| OPERATING INCOME | |||||||||||||||||||
| Operating Expenses | 64.6 | 66.1 | 59.9 | 75.4 | 50.9 | 74.7 | 72.6 | 48.6 | 28.7 | 8.8 | 7.7 | 6.9 | 17.7 | 14.6 | 19.9 | 21.4 | 20.6 | 11.2 | 6.8 |
| Selling, General and Administrative Expenses | 11.7 | 22.4 | 25.5 | 30.4 | 49.6 | 19.3 | 16.2 | 9.3 | 5.9 | 12.8 | 10.7 | 9.7 | 9.8 | 7.1 | 10.1 | 0 | 0 | 1.8 | 1.1 |
| Research and Development Expenses | 56.0 | 51.7 | 47.0 | 58.6 | 1.6 | 69.6 | 67.0 | 48.6 | 29.9 | 22.7 | 15.1 | 13.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (12.7) | (11.7) | (47.8) | (13.7) | (27.1) | 5.1 | (40.0) | 7.6 | (10.8) | (20.0) | (2.8) | (3.4) | (7.6) | (13.7) | (15.5) | (11.0) | (9.1) | (7.2) | (6.4) |
| PRE-TAX INCOME | |||||||||||||||||||
| Interest Income Expense | 0.6 | 5.3 | 4.0 | 6.8 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.5 | 0.5 | 0 | 0 | 0 | 2 K | 6 K |
| Total Other Income | 5.1 | (0.5) | 2.3 | (1.9) | 34.9 | (2.4) | (8.0) | 5.4 | 4.1 | 0.3 | 99 K | 0.2 | 0.6 | 32 K | 0.9 | 1.2 | 0.2 | 1.2 | 0.3 |
| Pre-Tax Income | (7.6) | (58.0) | (45.5) | (64.0) | (20.8) | 2.7 | (48.0) | 12.9 | (6.7) | (19.6) | (2.9) | (3.2) | (7.0) | (13.7) | (14.6) | (9.9) | (8.9) | (6.0) | (6.1) |
| NET INCOME | |||||||||||||||||||
| Tax Provision | 0 | 41.1 | 13.7 | 6.8 | 0.2 | (0.3) | 0.4 | 0.3 | 0.1 | 24 K | 51 K | (0.1) | 1.1 | 0 | 46 K | 0 | 51 K | 1.2 | 0.3 |
| Net Income | (7.6) | (99.1) | (59.1) | (70.7) | (21.0) | 3.0 | (48.4) | 12.6 | (6.7) | (19.6) | (2.9) | (3.2) | (7.0) | (13.7) | (14.6) | (9.9) | (8.9) | (6.0) | (6.1) |
| EPS | 0.0941 | 1.24 | 0.74 | 0.9 | 0.31 | 0.0519 | 0.89 | 0.23 | 0.13 | 0.39 | 0.0747 | 0.0846 | 0.19 | 0.36 | 0.56 | 0.38 | 0.36 | 0.34 | 0.41 |